Richard Hausmann has been named Chief Executive Officer, effective June 1, 2021. Hausmann will succeed Lennart Thurfjell, who will transition to the role of Chief Operating Officer.
Combinostics joined the EU funded Horizon 2020 project LETHE, a personalized prediction and intervention model for early detection and reduction of risk factors for dementia.
Combinostics congratulates Hanneke Rhodius-Meester at Alzheimercentrum Amsterdam for her nomination for Alzheimer Nederland's Young Outstanding Researcher (YOR) Award 2021.
ISO/IEC 27001:2013 is an ISMS standard and one of the most widely recognized certifications for information security controls and the identification and prevention of security risks.
A recent study led by the Alzheimer Center Amsterdam, Amsterdam UMC, and Combinostics found that the new cCOG tool is comparable to traditional pen-and-paper neuropsychology tests in detecting MCI and dementias.
Alzheimer's proteins in the cerebrospinal fluid play an increasingly important role in an accurate diagnosis. In this article, Dr. Hanneke Rhodius-Meester of the Alzheimer Center Amsterdam explains how cDSI can help doctors decide which patients are appropriate for a lumbar puncture.
Combinostics is pleased to announce the closure of a €3.9M series A funding round to extend the company's cNeuro platform in the US and Asia.
Combinostics is pleased to announce an exclusive partnership with Nihon Medi-Physics to develop and market the cNeuro platform in Japan.
Three peer-reviewed, scientific journals have published articles that describe the use of the cNeuro platform for dementias and other cognitive disorders.
Combinostics has been selected to join the 2019 MassChallenge HealthTech cohort which represents the most innovative technologies advancing health and improving the overall patient experience.